Cargando…
Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study)
BACKGROUND: It is uncertain that chronic heart failure (CHF) patients are susceptible to renal tubular damage with that of worsening renal function (WRF) preceding clinical outcomes. HYPOTHESIS: Changes in tubular damage biomarkers are stronger predictors of subsequent clinical events than changes i...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298997/ https://www.ncbi.nlm.nih.gov/pubmed/32298007 http://dx.doi.org/10.1002/clc.23359 |
_version_ | 1783547314840797184 |
---|---|
author | Brankovic, Milos Akkerhuis, K. Martijn Hoorn, Ewout J. van Boven, Nick van den Berge, Jan C. Constantinescu, Alina Brugts, Jasper van Ramshorst, Jan Germans, Tjeerd Hillege, Hans Boersma, Eric Umans, Victor Kardys, Isabella |
author_facet | Brankovic, Milos Akkerhuis, K. Martijn Hoorn, Ewout J. van Boven, Nick van den Berge, Jan C. Constantinescu, Alina Brugts, Jasper van Ramshorst, Jan Germans, Tjeerd Hillege, Hans Boersma, Eric Umans, Victor Kardys, Isabella |
author_sort | Brankovic, Milos |
collection | PubMed |
description | BACKGROUND: It is uncertain that chronic heart failure (CHF) patients are susceptible to renal tubular damage with that of worsening renal function (WRF) preceding clinical outcomes. HYPOTHESIS: Changes in tubular damage biomarkers are stronger predictors of subsequent clinical events than changes in creatinine (Cr), and both have different clinical determinants. METHODS: During 2.2 years, we repeatedly simultaneously collected a median of 9 blood and 8 urine samples per patient in 263 CHF patients. We determined the slopes (rates of change) of the biomarker trajectories for plasma (Cr) and urinary tubular damage biomarkers N‐acetyl‐β‐d‐glucosaminidase (NAG), and kidney‐injury‐molecule (KIM)‐1. The degree of tubular injury was ranked according to NAG and KIM‐1 slopes: increase in neither, increase in either, or increase in both; WRF was defined as increasing Cr slope. The composite endpoint comprised HF‐hospitalization, cardiac death, left ventricular assist device placement, and heart transplantation. RESULTS: Higher baseline NT‐proBNP and lower eGFR predicted more severe tubular damage (adjusted odds ratio, adj. OR [95%CI, 95% confidence interval] per doubling NT‐proBNP: 1.26 [1.07‐1.49]; per 10 mL/min/1.73 m(2) eGFR decrease 1.16 [1.03‐1.31]). Higher loop diuretic doses, lower aldosterone antagonist doses, and higher eGFR predicted WRF (furosemide per 40 mg increase: 1.32 [1.08‐1.62]; spironolactone per 25 mg decrease: 1.76 [1.07‐2.89]; per 10 mL/min/1.73 m(2) eGFR increase: 1.40 [1.20‐1.63]). WRF and higher rank of tubular injury individually entailed higher risk of the composite endpoint (adjusted hazard ratios, adj. HR [95%CI]: WRF 1.9 [1.1‐3.4], tubular 8.4 [2.6‐27.9]; when combined risk was highest 15.0 [2.0‐111.0]). CONCLUSION: Slopes of tubular damage and WRF biomarkers had different clinical determinants. Both predicted clinical outcome, but this association was stronger for tubular injury. Prognostic effects of both appeared independent and additive. |
format | Online Article Text |
id | pubmed-7298997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wiley Periodicals, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72989972020-06-18 Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study) Brankovic, Milos Akkerhuis, K. Martijn Hoorn, Ewout J. van Boven, Nick van den Berge, Jan C. Constantinescu, Alina Brugts, Jasper van Ramshorst, Jan Germans, Tjeerd Hillege, Hans Boersma, Eric Umans, Victor Kardys, Isabella Clin Cardiol Clinical Investigations BACKGROUND: It is uncertain that chronic heart failure (CHF) patients are susceptible to renal tubular damage with that of worsening renal function (WRF) preceding clinical outcomes. HYPOTHESIS: Changes in tubular damage biomarkers are stronger predictors of subsequent clinical events than changes in creatinine (Cr), and both have different clinical determinants. METHODS: During 2.2 years, we repeatedly simultaneously collected a median of 9 blood and 8 urine samples per patient in 263 CHF patients. We determined the slopes (rates of change) of the biomarker trajectories for plasma (Cr) and urinary tubular damage biomarkers N‐acetyl‐β‐d‐glucosaminidase (NAG), and kidney‐injury‐molecule (KIM)‐1. The degree of tubular injury was ranked according to NAG and KIM‐1 slopes: increase in neither, increase in either, or increase in both; WRF was defined as increasing Cr slope. The composite endpoint comprised HF‐hospitalization, cardiac death, left ventricular assist device placement, and heart transplantation. RESULTS: Higher baseline NT‐proBNP and lower eGFR predicted more severe tubular damage (adjusted odds ratio, adj. OR [95%CI, 95% confidence interval] per doubling NT‐proBNP: 1.26 [1.07‐1.49]; per 10 mL/min/1.73 m(2) eGFR decrease 1.16 [1.03‐1.31]). Higher loop diuretic doses, lower aldosterone antagonist doses, and higher eGFR predicted WRF (furosemide per 40 mg increase: 1.32 [1.08‐1.62]; spironolactone per 25 mg decrease: 1.76 [1.07‐2.89]; per 10 mL/min/1.73 m(2) eGFR increase: 1.40 [1.20‐1.63]). WRF and higher rank of tubular injury individually entailed higher risk of the composite endpoint (adjusted hazard ratios, adj. HR [95%CI]: WRF 1.9 [1.1‐3.4], tubular 8.4 [2.6‐27.9]; when combined risk was highest 15.0 [2.0‐111.0]). CONCLUSION: Slopes of tubular damage and WRF biomarkers had different clinical determinants. Both predicted clinical outcome, but this association was stronger for tubular injury. Prognostic effects of both appeared independent and additive. Wiley Periodicals, Inc. 2020-04-16 /pmc/articles/PMC7298997/ /pubmed/32298007 http://dx.doi.org/10.1002/clc.23359 Text en © 2020 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Investigations Brankovic, Milos Akkerhuis, K. Martijn Hoorn, Ewout J. van Boven, Nick van den Berge, Jan C. Constantinescu, Alina Brugts, Jasper van Ramshorst, Jan Germans, Tjeerd Hillege, Hans Boersma, Eric Umans, Victor Kardys, Isabella Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study) |
title | Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study) |
title_full | Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study) |
title_fullStr | Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study) |
title_full_unstemmed | Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study) |
title_short | Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study) |
title_sort | renal tubular damage and worsening renal function in chronic heart failure: clinical determinants and relation to prognosis (bio‐shift study) |
topic | Clinical Investigations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298997/ https://www.ncbi.nlm.nih.gov/pubmed/32298007 http://dx.doi.org/10.1002/clc.23359 |
work_keys_str_mv | AT brankovicmilos renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT akkerhuiskmartijn renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT hoornewoutj renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT vanbovennick renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT vandenbergejanc renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT constantinescualina renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT brugtsjasper renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT vanramshorstjan renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT germanstjeerd renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT hillegehans renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT boersmaeric renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT umansvictor renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy AT kardysisabella renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy |